about
Polypharmacy patterns: unravelling systematic associations between prescribed medicationsEffectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibrationDoes the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure.Similar multimorbidity patterns in primary care patients from two European regions: results of a factor analysisAge and gender differences in the prevalence and patterns of multimorbidity in the older population.Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyPrimary care utilisation patterns among an urban immigrant population in the Spanish National Health SystemMultimorbidity patterns in primary care: interactions among chronic diseases using factor analysis.Comorbidity of dementia: a cross-sectional study of primary care older patientsAssociation between physical activity, multimorbidity, self-rated health and functional limitation in the Spanish population.Primary health care use from the perspective of gender and morbidity burden.Multimorbidity and weight loss in obese primary care patients: longitudinal study based on electronic healthcare records.Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes.Multimorbidity and Its Patterns according to Immigrant Origin. A Nationwide Register-Based Study in NorwayGlobal healthcare use by immigrants in Spain according to morbidity burden, area of origin, and length of stay.Multimorbidity patterns: a systematic review.Poor congruence with guidelines in the use of antibiotics for acute bronchitis: a descriptive study based on electronic health records.Non-adherence to antihypertensive medication: The role of mental and physical comorbidity.Multimorbidity among registered immigrants in Norway: the role of reason for migration and length of stay.Global health care use by patients with type-2 diabetes: Does the type of comorbidity matter?The healthy migrant effect in primary care.Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.[Morbidity and drug consumption. Comparison of results between the National Health Survey and electronic medical records].Correction: Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis.Multimorbidity and immigrant status: associations with area of origin and length of residence in host country.Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study.How do immigrants use primary health care services? A register-based study in Norway.[Harmonisation of databases for the study of frailty in older people: INTAFRADE study].[Concordance in the registry of dementia among the main sources of clinical information].Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study.Adherence to chronic medication in older populations: application of a common protocol among three European cohortsEffectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyAntidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiatorsRisk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data SourcesThe definition of immigrant status matters: impact of nationality, country of origin, and length of stay in host country on mortality estimatesPatterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysisAdherence to treatment of hypertension, hypercholesterolaemia and diabetes in an elderly population of a Spanish cohortValidity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources
P50
Q28537875-F0BBB7B7-002F-4B4E-B9C2-9DC425021491Q30847108-741AC6A6-6F45-4FCD-891F-38D3160913D1Q33525713-AE2FC7A4-DD59-465C-9AB3-5163BB6B9501Q33575638-645F3ACB-EE61-469A-AA03-B8040B70FA41Q33793396-F95ECBE1-0888-4441-96AD-A6084D7C8AD1Q33804321-97A3DEA4-B816-4758-AFF2-3C71AE09D216Q33834390-D0E4CE80-15A6-4169-9C84-91A5CC6901B8Q33924471-F45DB9A8-328C-405B-A9A2-AA3EA4A8509EQ34185797-9C3B09DF-72B3-4942-8EDF-28A1AEF51087Q34410870-8F44C598-B748-48F7-8B3A-FFFBA50FE9DDQ34565396-6035F3D8-78CB-4D9E-9C75-EAEBF1EE0673Q34645654-CDB17AAC-49FA-4963-B512-F853733B7DA8Q35203985-0FE501EA-1CF0-40EA-A2D7-1A370869C492Q35711631-38BFDA88-5A84-4AC6-B9F8-2F73C28FC255Q35873272-B8B20799-EDB8-4B06-9FE7-1EBACB92B29BQ36031840-3FBCB824-E51B-47FD-A865-D6428610D276Q38182730-4506A51A-FDF4-4738-B8E6-0AABE3C76520Q39738762-2EEEE53A-8CFF-4ACE-B866-04AAA11BBE85Q40057462-41BBDBE9-B1D9-4E64-AE66-80BAD532B51DQ40477764-45119E0C-5F59-44A6-81B5-BC4B33A0DC6AQ43330541-725B6E5B-AF3D-471B-B73D-68598E691588Q44938329-4B34C5F4-714A-4583-94F0-98C44D47CFA8Q45113251-EEF2C3C6-F5BE-476C-A000-50E7A03E3C28Q46312106-505598C2-8760-4D9C-B397-2ACE441C94C6Q47125132-1C270C8E-38F7-4A8B-A12F-1565C2CAB297Q47626199-E1CF6DB3-7D7A-47BA-A9F4-2DF2CD2BFA6AQ49964385-ED4BEF87-1676-4AE2-B8BD-762525D40F47Q50107710-B9F48DFE-8069-4A75-BF3C-AF18EE7648EDQ50434638-5F66E487-94B4-440A-B342-0154EF94C193Q50436874-EAC54E26-CDDB-40F1-936E-66A214C672FDQ51767969-9F610E1F-765E-4A09-8EEC-678BD46F14B5Q55114858-F796C65B-EDE5-4138-B3B9-26B08F9CD676Q57483256-41E2304B-58C5-4D93-B84A-9D758FA1D6E0Q62023144-2219099A-B3A3-41B5-899D-8342EDEE77EEQ63951781-652615E5-BF2F-4C0E-AC8C-9FC1A2297052Q64067091-E0C1735D-5FDF-4907-BD24-4C394A6D34ECQ64086372-A6A5B6AF-3477-47BE-9863-3E2348E67C6BQ64232386-E0F525ED-ACCB-4540-A739-153AC40F0792Q90020311-1E3CD5D3-0DB7-446A-84A3-CD12416069C9Q92577771-D4B26A41-B147-4433-B6FD-EB33ED12237F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Beatriz Poblador-Plou
@ast
Beatriz Poblador-Plou
@en
Beatriz Poblador-Plou
@es
Beatriz Poblador-Plou
@nl
type
label
Beatriz Poblador-Plou
@ast
Beatriz Poblador-Plou
@en
Beatriz Poblador-Plou
@es
Beatriz Poblador-Plou
@nl
prefLabel
Beatriz Poblador-Plou
@ast
Beatriz Poblador-Plou
@en
Beatriz Poblador-Plou
@es
Beatriz Poblador-Plou
@nl
P106
P21
P31
P496
0000-0002-5119-5093